We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $9.16B
1-Year Est. Return 63.5%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+63.5%
3 Year Est. Return
+138.65%
5 Year Est. Return
+164.85%
10 Year Est. Return
+779.32%
AUM
$7.79B
AUM Growth
+$258M
Cap. Flow
-$64.7M
Cap. Flow %
-0.83%
Top 10 Hldgs %
23.95%
Holding
956
New
93
Increased
343
Reduced
426
Closed
25

Top Sells

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$19M
2
BE icon
Bloom Energy
BE
+$10.1M
3
VMEO
Vimeo
VMEO
+$7.67M
4
COHR icon
Coherent
COHR
+$7.21M
5
LRCX icon
Lam Research
LRCX
+$7.15M

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Financials 11.15%
3 Healthcare 10.99%
4 Industrials 8.59%
5 Communication Services 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VO icon
126
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$13.6M 0.17%
187,460
-2,792
-1% -$203K
ABT icon
127
Abbott
ABT
$185B
$13.4M 0.17%
107,341
-2,702
-2% -$344K
FORM icon
128
FormFactor
FORM
$8.48B
$13.4M 0.17%
239,778
-16,419
-6% -$827K
PANW icon
129
Palo Alto Networks
PANW
$283B
$13.3M 0.17%
72,369
+815
+1% +$164K
DIS icon
130
Walt Disney
DIS
$170B
$13.2M 0.17%
115,804
-11,350
-9% -$1.25M
LIND icon
131
Lindblad Expeditions
LIND
$2.17B
$13.1M 0.17%
909,499
-53,049
-6% -$669K
ARWR icon
132
Arrowhead Research
ARWR
$12.1B
$12.7M 0.16%
191,669
-11,645
-6% -$571K
TMO icon
133
Thermo Fisher Scientific
TMO
$213B
$12.5M 0.16%
21,637
-2,449
-10% -$1.38M
KO icon
134
Coca-Cola
KO
$374B
$12.5M 0.16%
178,824
-1,345
-0.7% -$93.8K
MRVL icon
135
Marvell Technology
MRVL
$174B
$12.5M 0.16%
146,709
-5,423
-4% -$475K
QCOM icon
136
Qualcomm
QCOM
$159B
$12.4M 0.16%
72,403
-1,047
-1% -$179K
T icon
137
AT&T
T
$162B
$12.3M 0.16%
496,772
-8,823
-2% -$223K
GILD icon
138
Gilead Sciences
GILD
$163B
$12.2M 0.16%
99,628
-3,713
-4% -$451K
CYTK icon
139
Cytokinetics
CYTK
$10.4B
$12.1M 0.16%
190,999
-10,491
-5% -$653K
BWXT icon
140
BWX Technologies
BWXT
$15.9B
$12.1M 0.16%
70,032
-2,377
-3% -$446K
COF icon
141
Capital One
COF
$134B
$11.9M 0.15%
49,256
+3,141
+7% +$699K
IEF icon
142
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$11.8M 0.15%
122,876
+3,577
+3% +$346K
FCX icon
143
Freeport-McMoran
FCX
$91.5B
$11.7M 0.15%
230,543
+7,590
+3% +$329K
UCTT
144
Ultra Clean Holdings
UCTT
$4B
$11.7M 0.15%
462,126
+68,450
+17% +$1.82M
AIOT
145
PowerFleet Inc
AIOT
$548M
$11.6M 0.15%
2,182,810
+784,505
+56% +$4.01M
CNI icon
146
Canadian National Railway
CNI
$76.1B
$11.6M 0.15%
117,024
-3,560
-3% -$342K
SPHR icon
147
Sphere Entertainment
SPHR
$5.29B
$11.5M 0.15%
121,022
-3,389
-3% -$258K
VRTX icon
148
Vertex Pharmaceuticals
VRTX
$119B
$11.4M 0.15%
25,238
-129
-0.5% -$55.6K
VZ icon
149
Verizon
VZ
$198B
$11.4M 0.15%
279,311
-49,713
-15% -$2.02M
MDT icon
150
Medtronic
MDT
$111B
$11.2M 0.14%
116,550
-3,621
-3% -$352K

Similar funds

Pinnacle Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Pinnacle Associates held 956 positions worth $7.79B, up 3.4% from $7.54B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Pinnacle Associates's Q4 2025 filing shows 93 new, 343 increased, 426 reduced and 25 closed positions. Its largest new stake was Procept Biorobotics: 123,194 shares worth $3.88M. The largest sale was Lumentum, an estimated $19M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Pinnacle Associates's largest Q4 2025 buy was Procept Biorobotics: 123,194 shares worth $3.88M.
  • Pinnacle Associates added most to NVIDIA in Q4 2025, an estimated $15.9M increase.
  • Pinnacle Associates's biggest Q4 2025 reduction was Lumentum, cutting an estimated $19M.
  • Pinnacle Associates fully exited Vimeo in Q4 2025, selling an estimated $7.67M.
  • Pinnacle Associates's ten largest holdings make up 24% of its $7.79B portfolio in Q4 2025.
  • Pinnacle Associates opened 93 new positions and closed 25 in Q4 2025.
  • Pinnacle Associates's portfolio value rose 3.4% quarter-over-quarter to $7.79B.

Based on Pinnacle Associates's 13F filing for Q4 2025, filed 5 Feb 2026.